Tryptamine Therapeutics (AU:TYP) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Tryptamine Therapeutics Limited has announced a non-pro rata offer to issue 10,000 ordinary fully paid shares, with the closing date for acceptances set for November 13, 2024. The proposed issue date for the securities is also November 13, 2024. This move is part of the company’s strategy to raise capital through the Australian Securities Exchange (ASX).
For further insights into AU:TYP stock, check out TipRanks’ Stock Analysis page.